Protocol | Published:

High-throughput fluorescence assay of cytochrome P450 3A4

Nature Protocols volume 4, pages 12581261 (2009) | Download Citation

Subjects

Abstract

Cytochrome P450 mono-oxygenases (P450s) are the principal enzymes involved in the oxidative metabolism of drugs and other xenobiotics. In this protocol, we describe a fluorescence-based, high-throughput assay for measuring the activity of P450 3A4, one of the key enzymes involved in drug metabolism. The assay involves the oxidative debenzylation of a substituted coumarin, yielding an increase in fluorescence on reaction. The entire procedure can be accomplished in 1 h or less.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Complex reactions catalyzed by cytochrome P450 enzymes. Biochim. Biophys. Acta. 1770, 314–329 (2007).

  2. 2.

    Human cytochrome P450 enzymes. in Cytochrome P450: Structure, Mechanism, and Biochemistry, 3rd edn. (ed. Ortiz de Montellano, P.R.) 377–530 (Kluwer Academic/Plenum Press, NY, USA, 2005).

  3. 3.

    et al. Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab. Dispos. 32, 1201–1208 (2004).

  4. 4.

    & Predicting in vivo drug interactions from in vitro drug discovery data. Nat. Rev. Drug Discov. 4, 825–833 (2005).

  5. 5.

    & In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions. AAPS J. 10, 410–424 (2008).

  6. 6.

    , , & Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay. Eur. J. Pharm. Sci. 24, 123–132 (2005).

  7. 7.

    , , & In vitro assessment of cytochrome P450 inhibition: strategies for increasing LC/MS-based assay throughput using a one-point IC50 method and multiplexing high-performance liquid chromatography. J. Pharm. Sci. 96, 2485–2493 (2007).

  8. 8.

    , , , & An automated, high-throughput, 384 well cytochrome P450 cocktail IC50 assay using a rapid resolution LC-MS/MS end-point. J. Pharm. Biomed. Anal. 48, 92–99 (2008).

  9. 9.

    , & Application of microtiter plate assay to evaluate inhibitory effects of various compounds on nine cytochrome P450 isoforms and to estimate their inhibition patterns. Drug Metab. Pharmacokinet. 17, 437–448 (2002).

  10. 10.

    , , , & A microtiter plate-based screening assay to assess diverse effects on cytochrome P450 enzyme activities in primary rat hepatocytes by various compounds. Assay Drug Dev. Technol. 3, 27–38 (2005).

  11. 11.

    & Enhancement of 7-methoxyresorufin O-demethylation of human cytochrome P450 1A2 by molecular breeding. Arch. Biochem. Biophys. 432, 102–108 (2004).

  12. 12.

    , & Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis. J. Biol. Chem. 280, 40319–40327 (2005).

  13. 13.

    , & Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal. Biochem. 248, 188–190 (1997).

  14. 14.

    , , & Design, synthesis, and characterization of 7-methoxy-4-(aminomethyl) coumarin as a novel and selective cytochrome P450 2D6 substrate suitable for high-throughput screening. Chem. Res. Toxicol. 12, 555–559 (1999).

  15. 15.

    , , , , & Coumarin substrates for cytochrome P450 2D6 fluorescence assays. Anal. Biochem. 292, 280–286 (2001).

  16. 16.

    et al. Luminogenic cytochrome P450 assays. Expert Opin. Drug Metab. Toxicol. 2, 629–645 (2006).

  17. 17.

    , & Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol. 15, 784–788 (1997).

Download references

Acknowledgements

Cytochrome P450 research in this laboratory is supported by United States Public Health Service grant R37 CA090426.

Author information

Affiliations

  1. Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee USA.

    • Qian Cheng
    • , Christal D Sohl
    •  & F Peter Guengerich

Authors

  1. Search for Qian Cheng in:

  2. Search for Christal D Sohl in:

  3. Search for F Peter Guengerich in:

Contributions

Q.C. performed and optimized the assays. Q.C. wrote most of the paper, with the assistance of F.P.G. and C.D.S. C.D.S. checked the protocols and helped Q.C. with data processing.

Corresponding author

Correspondence to F Peter Guengerich.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nprot.2009.123

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.